Stocks and Investing
Stocks and Investing
Tue, March 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Salim Syed Maintained (WVE) at Strong Buy with Increased Target to $19 on, Mar 12th, 2024
Salim Syed of Mizuho, Maintained "Wave Life Sciences Ltd." (WVE) at Strong Buy with Increased Target from $10 to $19 on, Mar 12th, 2024.
Salim has made no other calls on WVE in the last 4 months.
There are 3 other peers that have a rating on WVE. Out of the 3 peers that are also analyzing WVE, 1 agrees with Salim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $5 on, Thursday, March 7th, 2024
These are the ratings of the 2 analyists that currently disagree with Salim
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $15 on, Thursday, March 7th, 2024
- Mani Foroohar of "Leerink Partners" Upgraded from Hold to Buy and Held Target at $12 on, Tuesday, December 19th, 2023
Contributing Sources